Or maybe she knows that until they meet the final requirement of 6 months over USD 5.00 there is nothing to do. Also she has to do nothing. Mellon will do all the work for DY and market makers for CF. Since there are two there will be competition to be first. Putting LYC on the Nasdaq is a different thing altogether. Many more requirements. The ongoing expense is high as well. For instance they will have to keep two sets of books. One compliant with AU laws one compliant with US laws Every Q report and AR will have to be filled twice one with US compliant with their laws one with AU. Each set will need a full audit. Every time they do anything they will have to two separate fillings. This is why many foreign companies never put their main stock on a us exchange, just a tracking stock.
Just hope that CF and DY do not drop below USD5.00 even intraday. That resets the 6-month counter to zero.
LYC Price at posting:
$8.69 Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)